Mechanistically, the actions of LH/CG can be regulated at the level of the LH/CG receptor (LHR) by reducing the number of receptors (down- regulation) or by the functional uncoupling of a constant number of receptors from its effector system (uncoupling). We have previously shown that the hCG-induced down-regulation of the LHR is mostly due to the increased receptor degradation that ensues following endocytosis of the bound hormone. We have also shown that phosphorylation of the LHR is necessary but not sufficient for the hCG-induced uncoupling. The studies proposed herein seek to further our understanding of the molecular basis of uncoupling and down-regulation of the LHR.
The specific aims are as follows: (1) identify the kinases that phosphorylate the LHR and the residues that become phosphorylated; (2) examine the involvement of palmitoylation of the LHR on hCG-induced uncoupling; (3) determine the importance of LHR activation in LHR- mediated endocytosis; and (4) examine the molecular basis for the increased down-regulation of the LHR detected in Leydig tumor cells when compared to non-target cells expressing the recombinant LHR. While it is clear that changes in the levels of circulating hormones are effective means of modulating target cell responsiveness, emerging information about the regulation of hormone action at the level of their receptors argues that this level of regulation is equally effective and important. An efficient and highly specific way by which target cells regulate their responsiveness to continuous stimulation is by changing the functional properties or the numbers of hormone receptors. Our studies should thus provide valuable insights about the regulation of the function of the LHR, the glycoprotein hormone receptors and the G protein-coupled receptors in general.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA040629-15
Application #
2390665
Study Section
Biochemical Endocrinology Study Section (BCE)
Program Officer
Mohla, Suresh
Project Start
1998-02-15
Project End
2002-01-31
Budget Start
1998-02-15
Budget End
1999-01-31
Support Year
15
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Iowa
Department
Pharmacology
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Matzkin, Maria Eugenia; Yamashita, Soichi; Ascoli, Mario (2013) The ERK1/2 pathway regulates testosterone synthesis by coordinately regulating the expression of steroidogenic genes in Leydig cells. Mol Cell Endocrinol 370:130-7
Tai, Ping; Ascoli, Mario (2011) Reactive oxygen species (ROS) play a critical role in the cAMP-induced activation of Ras and the phosphorylation of ERK1/2 in Leydig cells. Mol Endocrinol 25:885-93
Yamashita, Soichi; Tai, Ping; Charron, Jean et al. (2011) The Leydig cell MEK/ERK pathway is critical for maintaining a functional population of adult Leydig cells and for fertility. Mol Endocrinol 25:1211-22
Tai, Ping; Shiraishi, Koji; Ascoli, Mario (2009) Activation of the lutropin/choriogonadotropin receptor inhibits apoptosis of immature Leydig cells in primary culture. Endocrinology 150:3766-73
Galet, Colette; Ascoli, Mario (2008) Arrestin-3 is essential for the activation of Fyn by the luteinizing hormone receptor (LHR) in MA-10 cells. Cell Signal 20:1822-9
Shiraishi, Koji; Ascoli, Mario (2008) A co-culture system reveals the involvement of intercellular pathways as mediators of the lutropin receptor (LHR)-stimulated ERK1/2 phosphorylation in Leydig cells. Exp Cell Res 314:25-37
Ascoli, Mario (2007) Potential Leydig cell mitogenic signals generated by the wild-type and constitutively active mutants of the lutropin/choriogonadotropin receptor (LHR). Mol Cell Endocrinol 260-262:244-8
Shiraishi, Koji; Ascoli, Mario (2007) Lutropin/choriogonadotropin stimulate the proliferation of primary cultures of rat Leydig cells through a pathway that involves activation of the extracellularly regulated kinase 1/2 cascade. Endocrinology 148:3214-25
Galet, Colette; Ascoli, Mario (2006) A constitutively active mutant of the human lutropin receptor (hLHR-L457R) escapes lysosomal targeting and degradation. Mol Endocrinol 20:2931-45
Shiraishi, Koji; Ascoli, Mario (2006) Activation of the lutropin/choriogonadotropin receptor in MA-10 cells stimulates tyrosine kinase cascades that activate ras and the extracellular signal regulated kinases (ERK1/2). Endocrinology 147:3419-27

Showing the most recent 10 out of 47 publications